These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2565903)

  • 1. A comparison of the properties of prenalterol and corwin at beta 1- and beta 2-adrenoreceptors in vitro.
    Gurden JM; Apperley GH; Drew GM
    J Auton Pharmacol; 1989 Apr; 9(2):79-91. PubMed ID: 2565903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The measurement of the relative efficacy of agonists by selective potentiation of tissue responses: studies with isoprenaline and prenalterol in cardiac tissue.
    Kenakin TP; Beek D
    J Auton Pharmacol; 1984 Sep; 4(3):153-9. PubMed ID: 6208197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cardiovascular pharmacology of xamoterol, cicloprolol, prenalterol and pindolol in the anaesthetised dog.
    Hadfield SE; Slee SJ; Snow HM
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):78S-81S. PubMed ID: 2572262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent regulation of beta 1- and beta 2-adrenoceptors.
    Beer M; Hacker S; Poat J; Stahl SM
    Br J Pharmacol; 1987 Dec; 92(4):827-34. PubMed ID: 2892556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic pharmacological properties of prenalterol.
    Mattsson H; Hedberg A; Carlsson E
    Acta Med Scand Suppl; 1982; 659():9-37. PubMed ID: 6127902
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of in vivo treatment with isoprenaline or prenalterol on beta-adrenoceptor mechanisms in the heart and soleus muscle of the cat.
    Hedberg A; Mattsson H; Nerme V; Carlsson E
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):251-8. PubMed ID: 6145101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectivity of xamoterol, prenalterol and salbutamol as assessed by their effects in the presence and absence of ICI 118 551.
    McCaffrey PM; Riddell JG; Shanks RG
    Eur Heart J; 1990 Apr; 11 Suppl A():54-5. PubMed ID: 1971592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of beta-adrenoceptor partial agonists on isolated rat atrium.
    Vigholt-Sørensen E; Påby L; Halliday SE; Snow HM
    Pharmacol Toxicol; 1991 Nov; 69(5):351-4. PubMed ID: 1687080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro pharmacology of xamoterol (ICI 118,587).
    Malta E; Mian MA; Raper C
    Br J Pharmacol; 1985 May; 85(1):179-87. PubMed ID: 2862938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic sympathomimetic activity of the partial agonist prenalterol in relation to beta adrenoceptor interaction in various tissues, in vitro.
    Mattsson H; Hedberg A; Carlsson E
    J Pharmacol Exp Ther; 1983 Mar; 224(3):654-61. PubMed ID: 6131123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta 1-Adrenoceptors mediating relaxation of the guinea-pig trachea: experiments with prenalterol, a beta 1-selective adrenoceptor agonist.
    Johansson U; Waldeck B
    J Pharm Pharmacol; 1981 Jun; 33(6):353-6. PubMed ID: 6115005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective and full beta 1-adrenoceptor agonist action of a catechol derivative of denopamine (T-0509) in the guinea-pig cardiac muscle and trachea: comparison with denopamine, xamoterol and isoprenaline.
    Yabana H; Watanabe H; Narita H; Nagao T
    Br J Pharmacol; 1992 Jun; 106(2):335-41. PubMed ID: 1356559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenalterol is an agonist at beta 2- as well as at beta 1-adrenoceptors.
    Apperley GH; Drew GM; Sullivan AT
    Eur J Pharmacol; 1982 Jul; 81(4):659-63. PubMed ID: 6126381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lack of a pronounced preference of prenalterol for the beta-l-adrenoceptor subtype.
    Rohm N; Wagner J; Schümann HJ
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(1):85-8. PubMed ID: 6113550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist.
    Tesfamariam B; Allen GT
    Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the beta-adrenergic inhibition of motility in cat colon strips.
    Ek B; Lundgren B
    Eur J Pharmacol; 1982 Jan; 77(1):25-31. PubMed ID: 6120845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the beta 1 selective affinity of prenalterol and corwin demonstrated by radioligand binding.
    Cook N; Richardson A; Barnett DB
    Eur J Pharmacol; 1984 Mar; 98(3-4):407-12. PubMed ID: 6144558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenoceptor profile of ractopamine HCl in isolated smooth and cardiac muscle tissues of rat and guinea-pig.
    Colbert WE; Williams PD; Williams GD
    J Pharm Pharmacol; 1991 Dec; 43(12):844-7. PubMed ID: 1687583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro pharmacological properties of a series of isoprenaline derivatives.
    Eigenmann R; Burkard WP; Holck M; Märki HP; Osterrieder W; Goodman M; Melmon KL
    Arzneimittelforschung; 1989 Aug; 39(8):842-7. PubMed ID: 2554933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.